首页> 外文期刊>European Journal of Pharmacology: An International Journal >Helium-induced cardioprotection of healthy and hypertensive rat myocardium in vivo
【24h】

Helium-induced cardioprotection of healthy and hypertensive rat myocardium in vivo

机译:氦气在体内对健康和高血压大鼠心肌的心脏保护作用

获取原文
获取原文并翻译 | 示例
           

摘要

Helium protects healthy myocardium against ischemia/reperfusion injury by early and late preconditioning (EPC, LPC) and postconditioning (PostC). We investigated helium-induced PostC of the hypertensive heart and enhancement by addition of LPC and EPC. We also investigated involvement of signaling kinases glycogen synthase kinase 3 beta (GSK-3β) and protein kinase C-epsilon (PKC-ε). To assess myocardial cell damage, we performed infarct size measurements in healthy Wistar Kyoto (WKY rats, n = 8-9) and Spontaneous Hypertensive rats (SHR, n = 8-9) subjected to 25 min ischemia and 120 min reperfusion. Rats inhaled 70% helium for 15 min after index ischemia (PostC), combined with 15 min helium 24 h prior to index ischemia (LPC + PostC), a triple intervention with additional 3 short cycles of 5 min helium inhalation shortly before ischemia (EPC + LPC + PostC), or no further treatment. In WKY rats, PostC reduced infarct size from 46 ± 2% (mean ± S.E.M) in the control group to 29 ± 2%. LPC + PostC or EPC + LPC + PostC reduced infarct sizes to a similar extent (30 ± 3% and 32 ± 2% respectively). In SHR, EPC + LPC + PostC reduced infarct size from 53 ± 3% in control to 39 ± 3%, while PostC or LPC + PostC alone were not protective; infarct size 48 ± 4% and 44 ± 4%, respectively. Neither PostC in WKY rats nor EPC + LPC + PostC in SHR was associated with an increase in phosphorylation of GSK-3β and PKC-ε after 15 min of reperfusion. Concluding, a triple intervention of helium conditioning results in cardioprotection in SHR, whereas a single intervention does not. In WKY rats, the triple intervention does not further augment protection. Helium conditioning is not associated with a mechanism involving GSK-3β and PKC-ε.
机译:氦气可通过早期和晚期预适应(EPC,LPC)和后适应(PostC)保护健康的心肌免受缺血/再灌注损伤。我们研究了氦诱导的高血压心脏的PostC和通过添加LPC和EPC的增强。我们还研究了信号激酶糖原合酶激酶3 beta(GSK-3β)和蛋白激酶C-ε(PKC-ε)的参与。为了评估心肌细胞损伤,我们对健康的Wistar Kyoto(WKY大鼠,n = 8-9)和自发性高血压大鼠(SHR,n = 8-9)进行了25分钟的局部缺血和120分钟的再灌注,进行了梗塞面积测量。大鼠在指数缺血(PostC)后15分钟吸入70%的氦气,再在指数缺血(LPC + PostC)前24 h吸入15分钟的氦气,这是三次干预,另外3个短周期即在缺血前(EPC)吸入5分钟的氦气+ LPC + PostC),否则无需进一步处理。在WKY大鼠中,PostC将梗死面积从对照组的46±2%(平均±S.E.M)降低到29±2%。 LPC + PostC或EPC + LPC + PostC将梗死面积缩小到相似的程度(分别为30±3%和32±2%)。在SHR中,EPC + LPC + PostC将梗死面积从对照组的53±3%减少到39±3%,而单独使用PostC或LPC + PostC则无保护作用。梗塞面积分别为48±4%和44±4%。 WKY大鼠中的PostC或SHR中的EPC + LPC + PostC都与再灌注15分钟后GSK-3β和PKC-ε磷酸化的增加无关。最后,氦气调理的三次干预可导致SHR的心脏保护,而单次干预则不会。在WKY大鼠中,三重干预不会进一步增强保护作用。氦气调节与涉及GSK-3β和PKC-ε的机制无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号